BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16951183)

  • 1. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.
    Mani A; Oh AS; Bowden ET; Lahusen T; Lorick KL; Weissman AM; Schlegel R; Wellstein A; Riegel AT
    Cancer Res; 2006 Sep; 66(17):8680-6. PubMed ID: 16951183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
    Lahusen T; Fereshteh M; Oh A; Wellstein A; Riegel AT
    Cancer Res; 2007 Aug; 67(15):7256-65. PubMed ID: 17671194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
    Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
    Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.
    Yi P; Feng Q; Amazit L; Lonard DM; Tsai SY; Tsai MJ; O'Malley BW
    Mol Cell; 2008 Feb; 29(4):465-76. PubMed ID: 18313384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.
    Tilli MT; Reiter R; Oh AS; Henke RT; McDonnell K; Gallicano GI; Furth PA; Riegel AT
    Mol Endocrinol; 2005 Mar; 19(3):644-56. PubMed ID: 15550471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
    Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
    Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
    Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
    Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
    Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRC-3 transcription-coupled activation, degradation, and the ubiquitin clock: is there enough coactivator to go around in cells?
    Lonard DM; O'Malley BW
    Sci Signal; 2008 Apr; 1(13):pe16. PubMed ID: 18385039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.
    Lahusen T; Henke RT; Kagan BL; Wellstein A; Riegel AT
    Breast Cancer Res Treat; 2009 Jul; 116(2):225-37. PubMed ID: 19418218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
    Anzick SL; Kononen J; Walker RL; Azorsa DO; Tanner MM; Guan XY; Sauter G; Kallioniemi OP; Trent JM; Meltzer PS
    Science; 1997 Aug; 277(5328):965-8. PubMed ID: 9252329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRC-3/AIB1: transcriptional coactivator in oncogenesis.
    Yan J; Tsai SY; Tsai MJ
    Acta Pharmacol Sin; 2006 Apr; 27(4):387-94. PubMed ID: 16539836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SRC-3 is required for prostate cancer cell proliferation and survival.
    Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
    Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoinositide 3-kinase/AKT signaling can promote AIB1 stability independently of GSK3 phosphorylation.
    Ferrero M; Avivar A; García-Macías MC; Font de Mora J
    Cancer Res; 2008 Jul; 68(13):5450-9. PubMed ID: 18593948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
    Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
    Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.
    Liao L; Kuang SQ; Yuan Y; Gonzalez SM; O'Malley BW; Xu J
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):3-14. PubMed ID: 12650696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients.
    Kirkegaard T; McGlynn LM; Campbell FM; Müller S; Tovey SM; Dunne B; Nielsen KV; Cooke TG; Bartlett JM
    Clin Cancer Res; 2007 Mar; 13(5):1405-11. PubMed ID: 17332282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression.
    Qin L; Liao L; Redmond A; Young L; Yuan Y; Chen H; O'Malley BW; Xu J
    Mol Cell Biol; 2008 Oct; 28(19):5937-50. PubMed ID: 18644862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA.
    Hossain A; Kuo MT; Saunders GF
    Mol Cell Biol; 2006 Nov; 26(21):8191-201. PubMed ID: 16940181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
    Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
    Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.